These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15949569)
1. Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma. Nagao K; Yamaguchi S; Matsuyama H; Korenaga Y; Hirata H; Yoshihiro S; Fukunaga K; Oba K; Naito K Cancer Genet Cytogenet; 2005 Jul; 160(1):43-8. PubMed ID: 15949569 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of allelic loss of chromosome region 5q22.3 approximately q23.2 in nonpapillary renal cell carcinoma. Nagao K; Yoshihiro S; Matsuyama H; Yamaguchi S; Oba K; Naito K Cancer Genet Cytogenet; 2002 Jul; 136(1):23-30. PubMed ID: 12165447 [TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785 [TBL] [Abstract][Full Text] [Related]
7. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014 [TBL] [Abstract][Full Text] [Related]
8. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478 [TBL] [Abstract][Full Text] [Related]
9. Smoking may cause genetic alterations at 5q22.2 approximately q23.1 in clear-cell renal cell carcinoma. Korenaga Y; Matsuyama H; Hirata H; Nagao K; Ohmi C; Sakano S; Yoshihiro S; Naito K Cancer Genet Cytogenet; 2005 Nov; 163(1):7-11. PubMed ID: 16271949 [TBL] [Abstract][Full Text] [Related]
10. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000 [TBL] [Abstract][Full Text] [Related]
12. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma. Chino K; Esumi M; Ishida H; Okada K J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214 [TBL] [Abstract][Full Text] [Related]
14. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966 [TBL] [Abstract][Full Text] [Related]
15. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma. Yamaguchi S; Yoshihiro S; Matsuyama H; Nagao K; Fukunaga K; Matsumoto H; Matsuda K; Oba K; Naito K Clin Genet; 2003 Mar; 63(3):184-91. PubMed ID: 12694227 [TBL] [Abstract][Full Text] [Related]
17. Evolving classification of renal cell neoplasia. Delahunt B; Velickovic M; Grebe SK Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090 [TBL] [Abstract][Full Text] [Related]
18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
19. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727 [TBL] [Abstract][Full Text] [Related]
20. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]